STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #279 by analyst upside · 2026-08-13
NNVC
NanoViricides, Inc.
Healthcare · Market Cap $35M · P/E 0x
ANALYST PRICE TARGET
+338.0%
implied upside to consensus target
Current Price $1.37
Consensus Target $6.0
Bull Target $6.0
Bear Target $6.0
Analysts Covering 2
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
2
Hold
0
Sell
0
52-Week Low $0.85
52-Week High $2.23
YTD Return +13.2%
FUNDAMENTALS
Market Cap $35M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.44
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.85
52-Week High $2.23
Current Price $1.37
Bear Target $6.0
Bull Target $6.0
● Now $1.37 ● Target $6.0
TRADING DATA
Avg Volume 945K
YTD Return +13.2%
Analyst Count 2
Consensus Buy
Upside to Target +338.0%
Last Updated 2026-08-13

ANALYST SUMMARY

NanoViricides, Inc. (NNVC) is currently trading at $1.37 with a Wall Street consensus price target of $6.0, implying potential upside of 338.0% over the next 12 months. 2 analysts currently cover NNVC, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $6.0, while the most cautious has a target of $6.0.

NNVC operates in the Healthcare sector with a market capitalisation of $35M. The stock is up 13.2% year-to-date and is currently trading near the lower end of its 52-week range of $0.85 – $2.23.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
43
out of 100
Coverage depth
8/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →